Gemcitabine-Induced Acute Myositis in a Patient with Duodenal Cancer

Clinical Oncology

Volumn 23, Issue 7, 2011, Pages 492-493

  Wong, K M ^a   Khanna, M ^a   Wu, R C ^a   Hedley, D W ^b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; GEMCITABINE;

ADENOCARCINOMA; ADULT; BURNING SENSATION; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CREATINE KINASE BLOOD LEVEL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DUODENUM CARCINOMA; EDEMA; ELECTROMYOGRAPHY; HUMAN; LETTER; MALE; MUSCLE NECROSIS; MYOSITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIDE EFFECT;

DEOXYCYTIDINE; DUODENAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MYOSITIS;

EID: 79960909047     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2011.02.007     Document Type: Letter

References (4)

1. Friedlander P.A., Bansal R., Schwartz L., Wagman R., Posner J., Kemeny N. Gemcitabine-related radiation recall preferentially involves internal tissue and organs. Cancer 2004, 100:1793-1799.
2. Toschi L., Finocchiaro G., Bartolini S., Gioia V., Cappuzzo F. Role of gemcitabine in cancer therapy. Future Oncol 2005, 1:7-17.
3. Sommers K.R., Kong K.M., Bui D.T., Fruehauf J.P., Holcombe R.F. Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient receiving concurrent radiation and gemcitabine. Anticancer Drugs 2003, 14:659-662.
4. Ardavanis A.S., Ioannidis G.N., Rigatos G.A. Acute myopathy in a patient with lung adenocarcinoma treated with gemcitabine and docetaxel. Anticancer Res 2005, 25:523-525.